Establishment of Second Source Sample Clauses

Establishment of Second Source. At such time as Lilly desires to establish one or more secondary supply sources (independent of any supply failure), but in no event earlier than [***] it shall so inform Sigilon and Sigilon shall cooperate with Lilly in establishing and qualifying such second source, at Lilly’s cost and expense, including enabling such designated second source to manufacture such quantities of Encapsulation Materials as are necessary to ensure that any such facilities are able to immediately fulfill Lilly’s requirements for Encapsulation Material in the event that Lilly’s rights under Section 7.3.2(b) are triggered. In furtherance of the foregoing, Sigilon shall conduct a manufacturing technology transfer as set forth in Section 7.5 to enable such second source Third Party manufacturer referred to above in Section 7.3.2(b) to be qualified to manufacture Encapsulation Materials.
Sample 1Sample 2
AutoNDA by SimpleDocs
Establishment of Second Source. (a) Within [***] of the Effective Date, MediWound must provide Vericel with true and accurate copies of all documents consistent with Schedule 2.7. If MediWound does not provide all documents within [***] of the Effective Date, Vericel’s obligation under Section 8.1 regarding the time period to provide MediWound with a notice of an extension of the Initial Term shall be extended by the amount of time beyond [***] taken by MediWound to provide the required documents.
Sample 1
Establishment of Second Source. If requested in writing by Astellas at any time after the date three (3) years following launch of a Product in a Major Market Country (and provided that Maxygen has not already established a second Approved Maxygen CMO for manufacture and supply of the applicable Bulk Drug Substance), Maxygen shall engage a second Approved Maxygen CMO for the purpose of supplying Bulk Drug Substance for such Product and transfer applicable manufacturing technology, as set forth in Section 6.1.6(c), to such Approved Maxygen CMO for the purpose of establishing a second supply source for Bulk Drug Substance for such Product. In such event, the Costs associated with the transfer of manufacturing technology pursuant to Section 6.1.6 shall be shared by the Parties as set forth in the Financial Exhibit. * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Xxxxxxxxxxxxxxx Xxxxxxx 6.1.6(b)(ii), above, if Maxygen’s Manufacturing Costs for commercial supply of Bulk Drug Substance from such second Approved Maxygen CMO exceeds [****] percent ([****]%) of the [****] of such Product, the price of such Bulk Drug Substance from such second Approved Maxygen CMO shall not be taken into account for purposes of determining the applicability of Section 6.1.6(b)(ii).
Sample 1

Related to Establishment of Second Source

  • Establishment of Securities Account The Securities Intermediary hereby confirms and agrees that:

  • Establishment of Series Subject to the provisions of this Agreement, the Managing Member may, at any time and from time to time and in compliance with paragraph (c), cause the Company to establish in writing (each, a Series Designation) one or more series as such term is used under Section 18-215 of the Delaware Act (each a Series). The Series Designation shall relate solely to the Series established thereby and shall not be construed: (i) to affect the terms and conditions of any other Series, or (ii) to designate, fix or determine the rights, powers, authority, privileges, preferences, duties, responsibilities, liabilities and obligations in respect of Interests associated with any other Series, or the Members associated therewith. The terms and conditions for each Series established pursuant to this Section shall be as set forth in this Agreement and the Series Designation, as applicable, for the Series. Upon approval of any Series Designation by the Managing Member, such Series Designation shall be attached to this Agreement as an Exhibit until such time as none of such Interests of such Series remain Outstanding.

  • Amendment of Section 4 4. Pursuant to Section 9.2 of the Indenture, Section 4.4(b) of the Indenture is hereby amended and restated in its entirety to read as follows:

  • Amendment of Section 8 15(b). Section 8.15(b) of the Existing Credit Agreement is hereby amended in its entirety to read as follows:

  • Amendment of Section 3 Section 3 of the Employment Agreement is hereby deleted in its entirety and replaced with the following: Term. Unless otherwise terminated in accordance with Sections 8, 9, 10 or 11, the Employment Term shall be for a term ending April 30, 2015. This Agreement shall be automatically renewed for successive additional Employment Terms of one (1) year each unless notice of termination is given in writing by either party to the other party at least thirty (30) days prior to the expiration of the initial Employment Term or any renewal Employment Term.

  • Amendment of Section 10 1. Section 10.1 of the Note Agreement is amended to read in its entirety as follows:

  • Amendment of Section 6 14. Section 6.14 of the Credit Agreement is amended to read as follows:

  • Amendment of Section 1 Section 1 of the Rights Agreement is supplemented to add the following definitions in the appropriate locations:

  • Establishment of Segregated Account Upon receipt of Proper Instructions, the Custodian shall establish and maintain on its books a segregated account or accounts for and on behalf of a Portfolio, into which account or accounts may be transferred cash and/or securities or other assets of such Portfolio, including securities maintained by the Custodian in a Securities System pursuant to Section 2.22(a) hereof or an Eligible Securities Depository pursuant to Section 2.22(b) hereof, said account or accounts to be maintained: (a) for the purposes set forth in Sections 2.09, 2.10 and 2.11 hereof; (b) for the purposes of compliance by the Portfolio with the procedures required by Investment Company Act Release No. 10666, or any subsequent release or releases of the SEC or SEC rules or regulations relating to the maintenance of segregated accounts by registered investment companies; or (c) for such other purposes as set forth, from time to time, in Special Instructions.

  • Amendment of Section 7 2.10(f). Clause (iii) of Section 7.2.10(f) of the Credit Agreement is hereby amended and restated in its entirety to the following:

Time is Money Join Law Insider Premium to draft better contracts faster.